Diffuse gliomas exhibit whole brain impaired cerebrovascular reactivity

Publication date: Available online 3 October 2017
Source:Magnetic Resonance Imaging
Author(s): Jorn Fierstra, Christiaan van Niftrik, Marco Piccirelli, Oliver Bozinov, Athina Pangalu, Niklaus Krayenbühl, Antonios Valavanis, Michael Weller, Luca Regli
PurposeCerebral diffuse gliomas exhibit perilesional impaired cerebrovascular reactivity (CVR), yet the degree of impairment as well as its full spatial extent in the brain remains unknown. With quantitative fMRI, we studied twelve subjects with untreated brain diffuse glioma and twelve healthy controls to assess CVR impairment and determine its distribution throughout the brain.MethodsIn a prospective case-control study, quantitative CVR measurements were derived from BOLD fMRI volumes during standardized iso-oxic changes in carbon dioxide. Whole brain CVR was assessed with additional detailed analyses using specific tumor and tissue masks and compared to datasets of healthy controls.ResultsWhole brain CVR was significantly impaired compared to healthy controls (0.11±0.10 versus 0.28±0.8, p<0.01). All diffuse glioma patients exhibited even more severely impaired intralesional CVR (mean 0.01±0.06). Increasing tumor volume significantly correlated with severity of intralesional CVR impairment (p<0.05, R²=0.38), and whole brain CVR impairment (p<0.05, R²=0.55).ConclusionPatients with brain diffuse glioma exhibit intralesional and whole brain impaired CVR with severity correlating to tumor volume. Quantitative fMRI may be entertained to study antitumor therapy efficacy by tracking CVR changes and may have a complementary role to better interpret BOLD associated neurovascular uncoupling.



http://ift.tt/2fJRbIW